Page 3
Approval for AKEEGA® is based on results from the Phase 3 MAGNITUDE study, a prospectively designed precision medicine study that includes the largest cohort to date of BRCA1/2-positive patients with untreated metastatic castration-resistant…
Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets. Full prescribing information is available on request or alternatively please go…
Biopharmaceutical company AbbVie launches new schools’ prize to help spark an interest in STEM New initiative will be rolled out to national schools in Dublin, Cork, Sligo and…
Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced today that Erleada®▼(apalutamide) has been granted reimbursement in Ireland for the treatment of adult men with metastatic hormone-sensitive prostate…
Clonmel Healthcare is delighted to announce the launch of Pirfenidone Clonmel 267mg and 801mg film-coated tablets. Pirfenidone Clonmel is indicated in adults for the treatment of mild to…
Upadacitinib is now approved by the European Commission for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost…
Windzor Pharma Ireland Ltd is please to announce the launch of SOLFEROL Softgel Capsules, a range of Vitamin D3 medicines , for the treatment of Vitamin D deficiency.…
Roxadustat is the first in a new class of orally administered hypoxia inducible factor prolyl hydroxylase (HIF PH) inhibitors licensed and reimbursed in Ireland The 2019 Nobel Prize…
CIBINQO ® is a once-daily oral treatment with proven efficacy demonstrated in a large-scale clinical trial program Pfizer Healthcare Ireland has today announced the availability of the 50…
Approval is based on data from the Phase 3 CASSIOPEIA trial, which demonstrated that the addition of daratumumab resulted in deeper response rates and improved progression-free survival (PFS)…
You’re all caught up.
